IRIS UniCatt

Tortora, Giampaolo
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 7.773
AS - Asia 7.302
EU - Europa 4.806
SA - Sud America 1.620
AF - Africa 223
OC - Oceania 40
Continente sconosciuto - Info sul continente non disponibili 6
Totale 21.770
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 7.482
SG - Singapore 3.193
CN - Cina 1.345
BR - Brasile 1.335
IT - Italia 1.188
VN - Vietnam 1.008
SE - Svezia 917
DE - Germania 572
FR - Francia 543
IN - India 462
GB - Regno Unito 288
IE - Irlanda 241
FI - Finlandia 229
PL - Polonia 219
ID - Indonesia 212
HK - Hong Kong 198
JP - Giappone 196
CA - Canada 136
RU - Federazione Russa 123
BD - Bangladesh 115
AR - Argentina 104
NL - Olanda 100
MX - Messico 94
IQ - Iraq 87
KR - Corea 80
TR - Turchia 75
AT - Austria 68
ES - Italia 68
ZA - Sudafrica 66
EC - Ecuador 62
PK - Pakistan 45
UA - Ucraina 45
CI - Costa d'Avorio 42
IR - Iran 37
SA - Arabia Saudita 37
AU - Australia 34
BE - Belgio 30
UZ - Uzbekistan 30
CO - Colombia 29
CZ - Repubblica Ceca 29
VE - Venezuela 28
PH - Filippine 27
LT - Lituania 23
EG - Egitto 20
JO - Giordania 20
CL - Cile 19
KE - Kenya 19
MA - Marocco 19
CH - Svizzera 18
AE - Emirati Arabi Uniti 16
RO - Romania 15
IL - Israele 14
DZ - Algeria 13
PY - Paraguay 13
TW - Taiwan 13
TN - Tunisia 12
AZ - Azerbaigian 11
GR - Grecia 11
JM - Giamaica 10
KZ - Kazakistan 10
PE - Perù 10
UY - Uruguay 10
BO - Bolivia 9
CR - Costa Rica 9
MY - Malesia 9
NP - Nepal 9
PT - Portogallo 9
TH - Thailandia 9
AL - Albania 8
LV - Lettonia 8
TT - Trinidad e Tobago 8
BG - Bulgaria 7
BY - Bielorussia 7
HN - Honduras 7
HU - Ungheria 7
LB - Libano 7
RS - Serbia 7
CY - Cipro 6
DO - Repubblica Dominicana 6
NZ - Nuova Zelanda 6
PA - Panama 6
ET - Etiopia 5
LU - Lussemburgo 5
NG - Nigeria 5
NI - Nicaragua 5
SN - Senegal 5
GE - Georgia 4
MM - Myanmar 4
PS - Palestinian Territory 4
BB - Barbados 3
BJ - Benin 3
EU - Europa 3
HR - Croazia 3
MD - Moldavia 3
OM - Oman 3
SI - Slovenia 3
SK - Slovacchia (Repubblica Slovacca) 3
SY - Repubblica araba siriana 3
XK - ???statistics.table.value.countryCode.XK??? 3
AO - Angola 2
Totale 21.728
Salva come PNG Salva come JPEG
Città #
Singapore 1.870
Ashburn 1.371
San Jose 764
Chandler 684
Rome 363
Ho Chi Minh City 346
Beijing 308
New York 258
Hanoi 257
Dublin 234
Hyderabad 232
Los Angeles 226
Hefei 222
Warsaw 198
Lauterbourg 194
Tokyo 188
Council Bluffs 184
Hong Kong 182
The Dalles 174
Frankfurt am Main 168
Fairfield 167
Jakarta 161
Milan 160
Chicago 140
São Paulo 137
Munich 133
Helsinki 131
Wilmington 109
Houston 103
Princeton 103
Boston 92
Seattle 89
Dallas 79
St Louis 79
San Mateo 76
Seoul 75
Orem 67
Santa Clara 67
London 66
Moscow 66
Kent 64
Woodbridge 59
Nuremberg 57
Marseille 56
Buffalo 54
Cambridge 54
Denver 52
Boardman 50
Cattolica 50
Turku 50
Da Nang 49
Lappeenranta 45
Brooklyn 44
Chennai 44
Paris 44
Abidjan 42
Düsseldorf 42
Johannesburg 41
Stockholm 41
Ann Arbor 40
Haiphong 40
Montreal 39
Vienna 39
Rio de Janeiro 37
Amsterdam 36
Mexico City 36
Toronto 34
Bremen 33
North Bergen 32
Atlanta 31
Baghdad 31
Phoenix 31
Poplar 31
Curitiba 30
Brussels 28
Manchester 28
Tashkent 26
Dhaka 25
Mumbai 25
Matera 24
Nanjing 24
Bexley 23
Guangzhou 23
Guayaquil 23
Salt Lake City 23
Shanghai 23
Belo Horizonte 22
Hải Dương 22
Augusta 21
Dearborn 21
Goiânia 21
Naples 21
Washington 21
Amman 20
Falkenstein 20
Brno 19
Campinas 19
Porto Alegre 19
Portsmouth 19
Ankara 18
Totale 12.559
Salva come PNG Salva come JPEG
Nome #
Discordance of KRAS Mutational Status between Primary Tumors and Liver Metastases in Colorectal Cancer: Impact on Long-Term Survival Following Radical Resection 614
Pembrolizumab as first-line treatment for metastatic uveal melanoma 342
C-myc expression is a possible keystone in the colorectal cancer resistance to egfr inhibitors 320
A digital solution to support the activities: Multidisciplinary Tumor Board process and impact analysis 310
Translational Research in the Era of Precision Medicine: Where We Are and Where We Will Go 279
Gene Expression Profiling of Lung Atypical Carcinoids and Large Cell Neuroendocrine Carcinomas Identifies Three Transcriptomic Subtypes with Specific Genomic Alterations 245
Diagnosis and treatment of bone metastases in breast cancer: Radiotherapy, local approach and systemic therapy in a guide for clinicians 219
Impact of muscle mass loss on outcomes in advanced or metastatic gastric cancer patients receiving a second-line treatment 211
c-MYC Expression Is a Possible Keystone in the Colorectal Cancer Resistance to EGFR Inhibitors. 207
Development of a digital research assistant for the management of patients’ enrollment in oncology clinical trials within a research hospital 197
The impact of the multidisciplinary tumor board (MDTB) on the management of pancreatic diseases in a tertiary referral center 190
Liver metastasectomy for metastatic breast cancer patients: A single institution retrospective analysis 184
Gut microbiome, big data and machine learning to promote precision medicine for cancer 180
An alternative splicing signature defines the basal-like phenotype and predicts worse clinical outcome in pancreatic cancer 178
Immunotherapy and radiotherapy in melanoma: a multidisciplinary comprehensive review 174
Safety and efficacy of endoscopic ultrasound-guided radiofrequency ablation for pancreatic insulinoma: A single-center experience 171
Blood serum amyloid A as potential biomarker of pembrolizumab efficacy for patients affected by advanced non-small cell lung cancer overexpressing PD-L1: results of the exploratory “FoRECATT” study 170
Lung cancer multi-omics digital human avatars for integrating precision medicine into clinical practice: the LANTERN study 169
Identification of spatially-resolved markers of malignant transformation in Intraductal Papillary Mucinous Neoplasms 166
Liver metastasectomy for metastatic breast cancer patients: A single institution retrospective analysis 163
Targeted next-generation sequencing identifies genomic abnormalities potentially driving the prognosis of early-stage invasive lobular breast carcinoma patients stratified according to a validated clinico-pathological model 158
Development of a digital research assistant for the management of patients’ enrollment in oncology clinical trials within a research hospital 158
Management of the kidney transplant patient with Cancer: Report from a Multidisciplinary Consensus Conference 158
Challenges in crohn’s disease management after gastrointestinal cancer diagnosis 156
The likelihood of being helped or harmed as a patient-centred tool to assess cyclin dependent kinase 4/6 inhibitors clinical impact and safety in metastatic breast cancer: a systematic review and sensitivity-analysis 155
BRCA Mutation Status in Triple-Negative Breast Cancer Patients Treated with Neoadjuvant Chemotherapy: A Pivotal Role for Treatment Decision-Making 152
Management of single pulmonary metastases from colorectal cancer: State of the art 152
Management of the kidney transplant patient with Cancer: Report from a Multidisciplinary Consensus Conference 151
Clinical, pathological and prognostic features of rare braf mutations in metastatic colorectal cancer (Mcrc): A bi-institutional retrospective analysis (rebus study) 150
Hepatic Radiotherapy in Addition to Anti-PD-1 for the Treatment of Metastatic Uveal Melanoma Patients 149
191P Radiotherapy (RT) in oligoprogressive metastatic breast cancer (mBC): A retrospective analysis 149
Benefit of a multimodal approach combining chemotherapy and surgery in oligometastatic gastric cancer: experience from a tertiary referral center 148
Let‐7a‐5p, mir‐100‐5p, mir‐101‐3p, and mir‐199a‐3p hyperexpression as potential predictive biomarkers in early breast cancer patients 145
Intratumoral injection of TLR9 agonist promotes an immunopermissive microenvironment transition and causes cooperative antitumor activity in combination with anti-PD1 in pancreatic cancer 145
Preoperative low skeletal muscle mass index assessed using L3-CT as a prognostic marker of clinical outcomes in pancreatic cancer patients undergoing surgery: A systematic review and meta-analysis. 144
Dynamics of RAS/BRAF Mutations in cfDNA from Metastatic Colorectal Carcinoma Patients Treated with Polychemotherapy and Anti-EGFR Monoclonal Antibodies 144
Nutritional Interventions during Chemotherapy for Pancreatic Cancer: A Systematic Review of Prospective Studies 143
Palbociclib plus fulvestrant or everolimus plus exemestane for pretreated advanced breast cancer with lobular histotype in er+/her2− patients: A propensity score-matched analysis of a multicenter retrospective patient series 143
Body composition changes in gastric cancer patients during preoperative flot therapy: Preliminary results of an italian cohort study 143
Skeletal Muscle Loss during Multikinase Inhibitors Therapy: Molecular Pathways, Clinical Implications, and Nutritional Challenges. 140
Symptomatic androgen deficiency and sexual dysfunctions in male patients receiving alectinib for ALK-positive advanced nonsmall cell lung cancer 139
Radiotherapy benefit in oligoprogressive breast cancer: A retrospective analysis 137
Body composition derangements in lung cancer patients treated with first-line pembrolizumab: A multicentre observational study 134
Comparison of first-line chemotherapy regimens in unresectable locally advanced or metastatic pancreatic cancer: a systematic review and Bayesian network meta-analysis 133
PTEN Loss as a Predictor of Tumor Heterogeneity and Poor Prognosis in Patients With EGFR-mutant Advanced Non–small-cell Lung Cancer Receiving Tyrosine Kinase Inhibitors 133
Accessible model predicts response in hormone receptor positive HER2 negative breast cancer receiving neoadjuvant chemotherapy 132
Large Cell Neuro-Endocrine Carcinoma of the Lung: Current Treatment Options and Potential Future Opportunities 131
Impact of Comprehensive Genome Profiling on the Management of Advanced Non–Small Cell Lung Cancer: Preliminary Results From the Lung Cancer Cohort of the FPG500 Program 130
Dabrafenib-Trametinib and Radiotherapy for Oligoprogressive BRAF Mutant Advanced Melanoma 130
Conversion Therapy With Encorafenib and Cetuximab for Chemo-Refractory BRAF V600E-Mutated Liver-Limited Colorectal Cancer Metastasis: The First Case Report 129
Mutational status of plasma exosomal KRAS predicts outcome in patients with metastatic colorectal cancer 129
Development of a nomogram for predicting pathological complete response in luminal breast cancer patients following neoadjuvant chemotherapy 128
The Impact of a Multidisciplinary Tumor Board (MDTB) in the Management of Colorectal Cancer (CRC) 128
Conjunctival melanoma: Genetic and epigenetic insights of a distinct type of melanoma 128
Skin cancer triage and management during COVID-19 pandemic. 128
Nutritional Interventions during Chemotherapy for Pancreatic Cancer: A Systematic Review of Prospective Studies 127
Contemporary Analysis of cardiac Tamponade Etiologies, Treatments, and Outcomes: the CATEO Study 127
An IT Platform Supporting Rectal Cancer Tumor Board Activities: Implementation Process and Impact Analysis 127
CXCR1/2 dual-inhibitor ladarixin reduces tumour burden and promotes immunotherapy response in pancreatic cancer 125
Immune-checkpoint inhibitors in renal transplanted patients affected by melanoma: A systematic review 125
Muscle mass, assessed at diagnosis by L3-CT scan as a prognostic marker of clinical outcomes in patients with gastric cancer: A systematic review and meta-analysis. 124
Effects of nutritional interventions on nutritional status in patients with gastric cancer: A systematic review and meta-analysis of randomized controlled trials 124
Oncogene-addicted non-small-cell lung cancer: Treatment opportunities and future perspectives 124
Mutational status of plasma exosomal KRAS predicts outcome in patients with metastatic colorectal cancer 124
Radiomics to predict immunotherapy efficacy in advanced renal cell carcinoma: A retrospective study 123
Surgery for locally advanced gastric cancer in the era of neoadjuvant therapies: something new? 121
Integrating a Comprehensive Cancer Genome Profiling into Clinical Practice: A Blueprint in an Italian Referral Center 121
Immunological backbone of uveal melanoma: Is there a rationale for immunotherapy? 121
Targeting hypoxia-inducible factor pathways in sporadic and Von Hippel-Lindau syndrome-related kidney cancers 119
Real-world outcomes of Adjuvant De Gramont versus Xelox chemotherapy in reSected gasTric cancER: a propensity score-matched analysis (ASTER study) 119
Theranostics revolution in prostate cancer: Basics, clinical applications, open issues and future perspectives 119
Biomarkers of response to advanced prostate cancer therapy 119
Going towards a precise definition of the therapeutic management of de-novo metastatic castration sensitive prostate cancer patients: How prognostic classification impact treatment decisions 118
Bevacizumab as maintenance therapy in patients with metastatic colorectal cancer: A meta-analysis of individual patients’ data from 3 phase III studies 118
Challenges in Crohn's Disease Management after Gastrointestinal Cancer Diagnosis 117
Role of chemoradiation (CRT) in the adjuvant treatment of radically resected pancreatic cancer (PC) patients (pts): a mono-institutional retrospective analysis 117
Impact on survival of primary tumor resection in patients with metastatic breast cancer: preliminary results of a retrospective analisys 117
Prognostic factors affecting survival after pulmonary resection of metastatic renal cell carcinoma: A multicenter experience 117
Talniflumate abrogates mucin immune suppressive barrier improving efficacy of gemcitabine and nab-paclitaxel treatment in pancreatic cancer 116
Dabrafenib and Trametinib in BRAF Mutant Metastatic Conjunctival Melanoma 116
Novel epigenetic eight-gene signature predictive of poor prognosis and msi-like phenotype in human metastatic colorectal carcinomas 115
Dupilumab-associated ocular adverse events are predicted by low tear break-up time and correlate with high IL-33 tear concentrations in patients with atopic dermatitis 114
Adjuvant nab-Paclitaxel + Gemcitabine in Resected Pancreatic Ductal Adenocarcinoma: Results from a Randomized, Open-Label, Phase III Trial 114
Adjuvant denosumab in early breast cancer: a systematic review and meta-analysis of randomized controlled clinical trials 112
Efficacy of third-line anti-EGFR-based treatment versus regorafenib or trifluridine/tipiracil according to primary tumor site in RAS/BRAF wild-type metastatic colorectal cancer patients 112
Faecal microbiota transplantation for the treatment of diarrhoea induced by tyrosine-kinase inhibitors in patients with metastatic renal cell carcinoma 111
Erdafitinib versus pembrolizumab in pretreated patients with advanced or metastatic urothelial cancer with select FGFR alterations: cohort 2 of the randomized phase III THOR trial 110
Clinical Stage III NSCLC Patients Treated with Neoadjuvant Therapy and Surgery: The Prognostic Role of Nodal Characteristics 110
Codon-specific KRAS mutations predict survival benefit of trifluridine/tipiracil in metastatic colorectal cancer 109
COVALENCE STUDY: Immunogenicity and Reactogenicity of a COVID-19 mRNA Vaccine in an Open-Label Cohort of Long-Survivor Patients with Metastatic Lung Cancer 109
SOMATOSTATIN ANALOGUES VS ACTIVE SURVEILLANCE IN SMALL PANCREATIC NEUROENDOCRINE TUMORS 109
Prognostic Model for Resected Squamous Cell Lung Cancer: External Multicenter Validation and Propensity Score Analysis exploring the Impact of Adjuvant and Neoadjuvant Treatment 109
Post-traumatic growth in oncological patients during the COVID-19 pandemic 108
Role of Chemoradiation in the Adjuvant Treatment of Radically Resected Pancreatic Cancer Patients: A Mono-Institutional Retrospective Analysis 107
Exploring the molecular and biological background of lung neuroendocrine tumours 107
PD-L1 Expression in de Novo Metastatic Castration-sensitive Prostate Cancer 107
Post-traumatic growth in oncological patients during the COVID-19 pandemic 106
PD-L1 for selecting non-small-cell lung cancer patients for first-line immuno-chemotherapy combination: A systematic review and meta-analysis 106
Correction: Lung cancer multi-omics digital human avatars for integrating precision medicine into clinical practice: the LANTERN study 106
Nutritional Support in Lung Cancer Patients: The State of the Art 105
Totale 14.852
Salva come PNG Salva come JPEG
Categoria #
all - tutte 89.360
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 89.360
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021161 0 0 0 0 0 0 0 0 0 51 78 32
2021/20221.056 123 40 26 111 44 38 19 134 50 35 225 211
2022/20232.290 327 288 166 313 127 253 139 164 227 82 100 104
2023/20242.118 59 321 81 88 85 201 366 321 45 82 185 284
2024/20254.517 96 84 319 158 273 153 269 154 579 660 906 866
2025/202611.067 1.414 507 824 1.760 1.944 567 1.914 654 824 659 0 0
Totale 22.160